Liesbeth Minnoye

Liesbeth Minnoye

Auto-generated profile, based on publicly available information

Liesbeth Minnoye

VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
CGCarmen Bravo González-Blas
Carmen Bravo González-Blas
LMLiesbeth Minnoye
Liesbeth Minnoye
DPDafni Papasokrati
Dafni Papasokrati
SASara Aibar
Sara Aibar
GHGert Hulselmans
Gert Hulselmans
SAStein Aerts
Stein Aerts

3 August 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
JWJasper Wouters
Jasper Wouters
ZKZeynep Kalender-Atak
Zeynep Kalender-Atak
LMLiesbeth Minnoye
Liesbeth Minnoye
KSKatina I. Spanier
Katina I. Spanier
MWMaxime De Waegeneer
Maxime De Waegeneer
SAStein Aerts
Stein Aerts

12 January 2018 in Briefings in Functional Genomics
Verified
Journal Article
Open access
PDF file
MFMark W E J Fiers
Mark W E J Fiers
LMLiesbeth Minnoye
Liesbeth Minnoye
SASara Aibar
Sara Aibar
CGCarmen Bravo González-Blas
Carmen Bravo González-Blas
ZAZeynep Kalender Atak
Zeynep Kalender Atak
SAStein Aerts
Stein Aerts
Single-cell techniques are advancing rapidly and are yielding unprecedented insight into cellular heterogeneity. Mapping the gene regulatory networks (GRNs) underlying cell states provides attractive opportunities to mechanistically understand this heterogeneity. In this review, we discuss recently emerging methods to map GRNs from single-cell transcriptomics data, tackling the challenge of increased noise levels and data sparsity compared with bulk data, alongside increasing data volumes. Next, we discuss how new techniques for single-cell epigenomics, such as single-cell ATAC-seq and single-cell DNA methylation profiling, can be used to decipher gene regulatory programmes. We finally look forward to the application of single-cell multi-omics and perturbation techniques that will likely play important roles for GRN inference in the future.

21 January 2021 in Nature Reviews Methods Primers
Verified
Journal Article
Closed access
PDF file
LMLiesbeth Minnoye
Liesbeth Minnoye
GMGeorgi K. Marinov
Georgi K. Marinov
TKThomas Krausgruber
Thomas Krausgruber
LPLixia Pan
Lixia Pan
AMAlexandre P. Marand
Alexandre P. Marand
SAStein Aerts
Stein Aerts

30 July 2020 in Genome Research
Verified
Journal Article
Open access
PDF file
LMLiesbeth Minnoye
Liesbeth Minnoye
ITIbrahim Ihsan Taskiran
Ibrahim Ihsan Taskiran
DMDavid Mauduit
David Mauduit
MFMaurizio Fazio
Maurizio Fazio
LALinde Van Aerschot
Linde Van Aerschot
SAStein Aerts
Stein Aerts
Deciphering the genomic regulatory code of enhancers is a key challenge in biology because this code underlies cellular identity. A better understanding of how enhancers work will improve the interpretation of noncoding genome variation and empower the generation of cell type–specific drivers for gene therapy. Here, we explore the combination of deep learning and cross-species chromatin accessibility profiling to build explainable enhancer models. We apply this strategy to decipher the enhancer code in melanoma, a relevant case study owing to the presence of distinct melanoma cell states. We trained and validated a deep learning model, called DeepMEL, using chromatin accessibility data of 26 melanoma samples across six different species. We show the accuracy of DeepMEL predictions on the CAGI5 challenge, where it significantly outperforms existing models on the melanoma enhancer of IRF4. Next, we exploit DeepMEL to analyze enhancer architectures and identify accurate transcription factor binding sites for the core regulatory complexes in the two different melanoma states, with distinct roles for each transcription factor, in terms of nucleosome displacement or enhancer activation. Finally, DeepMEL identifies orthologous enhancers across distantly related species, where sequence alignment fails, and the model highlights specific nucleotide substitutions that underlie enhancer turnover. DeepMEL can be used from the Kipoi database to predict and optimize candidate enhancers and to prioritize enhancer mutations. In addition, our computational strategy can be applied to other cancer or normal cell types.

16 July 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
CGCarmen Bravo González-Blas
Carmen Bravo González-Blas
LMLiesbeth Minnoye
Liesbeth Minnoye
DPDafni Papasokrati
Dafni Papasokrati
SASara Aibar
Sara Aibar
GHGert Hulselmans
Gert Hulselmans
SAStein Aerts
Stein Aerts
Single-cell epigenomics provides new opportunities to decipher genomic regulatory programs from heterogeneous samples and dynamic processes. We present a probabilistic framework called cisTopic, to simultaneously discover “cis-regulatory topics” and stable cell states from sparse single-cell epigenomics data. After benchmarking cisTopic on single-cell ATAC-seq data, single-cell DNA methylation data, and semi-simulated single-cell ChIP-seq data, we use cisTopic to predict regulatory programs in the human brain and validate these by aligning them with co-expression networks derived from single-cell RNA-seq data. Next, we performed a time-series single-cell ATAC-seq experiment after SOX10 perturbations in melanoma cultures, where cisTopic revealed dynamic regulatory topics driven by SOX10 and AP-1. Finally, machine learning and enhancer modelling approaches allowed to predict cell type specific SOX10 and SOX9 binding sites based on topic specific co-regulatory motifs. cisTopic is available as an R/Bioconductor package at http://github.com/aertslab/cistopic .